Cartesian Therapeutics Statistics
Total Valuation
RNAC has a market cap or net worth of $316.33 million. The enterprise value is $117.70 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RNAC has 25.91 million shares outstanding. The number of shares has increased by 235.72% in one year.
| Current Share Class | 25.91M |
| Shares Outstanding | 25.91M |
| Shares Change (YoY) | +235.72% |
| Shares Change (QoQ) | +18.40% |
| Owned by Insiders (%) | 58.57% |
| Owned by Institutions (%) | 27.57% |
| Float | 9.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.42 |
| Forward PS | 86.83 |
| PB Ratio | -46.50 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.43
| Current Ratio | 9.43 |
| Quick Ratio | 9.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.00% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -8.62% |
| Revenue Per Employee | $589,591 |
| Profits Per Employee | -$1.17M |
| Employee Count | 66 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RNAC has paid $287,000 in taxes.
| Income Tax | 287,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.25% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -43.25% |
| 50-Day Moving Average | 14.92 |
| 200-Day Moving Average | 17.29 |
| Relative Strength Index (RSI) | 47.80 |
| Average Volume (20 Days) | 126,838 |
Short Selling Information
The latest short interest is 2.38 million, so 9.20% of the outstanding shares have been sold short.
| Short Interest | 2.38M |
| Short Previous Month | 2.10M |
| Short % of Shares Out | 9.20% |
| Short % of Float | 25.62% |
| Short Ratio (days to cover) | 17.56 |
Income Statement
In the last 12 months, RNAC had revenue of $38.91 million and -$77.42 million in losses. Loss per share was -$4.49.
| Revenue | 38.91M |
| Gross Profit | -5.99M |
| Operating Income | -35.52M |
| Pretax Income | -248.65M |
| Net Income | -77.42M |
| EBITDA | -34.37M |
| EBIT | -35.52M |
| Loss Per Share | -$4.49 |
Full Income StatementBalance Sheet
The company has $212.61 million in cash and $13.98 million in debt, giving a net cash position of $198.63 million or $7.67 per share.
| Cash & Cash Equivalents | 212.61M |
| Total Debt | 13.98M |
| Net Cash | 198.63M |
| Net Cash Per Share | $7.67 |
| Equity (Book Value) | -6.80M |
| Book Value Per Share | -0.26 |
| Working Capital | 193.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$23.67 million and capital expenditures -$9.09 million, giving a free cash flow of -$32.77 million.
| Operating Cash Flow | -23.67M |
| Capital Expenditures | -9.09M |
| Free Cash Flow | -32.77M |
| FCF Per Share | -$1.26 |
Full Cash Flow StatementMargins
Gross margin is -15.40%, with operating and profit margins of -91.28% and -198.97%.
| Gross Margin | -15.40% |
| Operating Margin | -91.28% |
| Pretax Margin | -198.23% |
| Profit Margin | -198.97% |
| EBITDA Margin | -88.32% |
| EBIT Margin | -91.28% |
| FCF Margin | n/a |
Dividends & Yields
RNAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -235.72% |
| Shareholder Yield | -235.72% |
| Earnings Yield | -24.48% |
| FCF Yield | -10.36% |
Analyst Forecast
The average price target for RNAC is $41.20, which is 245.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.20 |
| Price Target Difference | 245.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 44.24% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.0333333:1.
| Last Split Date | Apr 5, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0333333:1 |
Scores
RNAC has an Altman Z-Score of -1.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.42 |
| Piotroski F-Score | 3 |